In addition, certain oncogenic EV cargo, including miR-155 in pancreatic cancer, has been shown to target tumor suppressors like TP53 and TP53INP1 to promote CAF activation [21,26]. Here, TP53INP1 is linked to familial pancreatic carcinoma.